PB Evidence-Based Mental Health
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2006) 30: 131-134. doi: 10.1192/pb.30.4.131
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Loughlin, C.
Right arrow Articles by Darley, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by O’Loughlin, C.
Right arrow Articles by Darley, J.
Psychiatric Bulletin (2006) 30: 131-134
© 2006 The Royal College of Psychiatrists

Has the referral of older adults with dementia changed since the availability of acetylcholinesterase inhibitors and the NICE guidelines?

Christopher O’Loughlin, Specialist Registrar

Old Age Psychiatry, Older Peoples’Mental Health Service, Box 311, OPMHS Office, Fulbourn Hospital, Cambridge CB15EF, e-mail: c.oloughlin{at}btinternet.com

Jon Darley, Consultant

Old Age Psychiatry, West Suffolk Hospital, Bury St Edmunds

Declaration of interest

None.

AIMS AND METHOD

To investigate whether patients with dementia are referred to specialist services earlier in the disease since the launch of acetylcholinesterase inhibitors and the publication of the National Institute for Clinical Excellence (NICE) guidelines for the use of these drugs. All referrals to old age psychiatry services in two 6-month periods in 1996 and 2003 were surveyed retrospectively for diagnosis, Mini-Mental State Examination (MMSE) score and use of acetylcholinesterase inhibitors.

RESULTS

The mean MMSE score at referral increased from 18.8 to 21.5 (P=0.0005) between 1996 and 2003. Acetylcholinesterase inhibitors were prescribed for 35% of all patients and 58% of patients that would be suitable according to NICE guidelines in the 2003 group.

CLINICAL IMPLICATIONS

The earlier referral of patients with dementia to mental health services is encouraging.




eLetters:

Read all eLetters

IMPACT OF NICE GUIDELINES on Memory Clinic Referrals has already been Studied
Dr. Zaffar Ul Hassan
PB Online, 20 Apr 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2006 The Royal College of Psychiatrists.